Riskpilot← Back to searchSign inGet full accessDaniel Stern Dermatologi AB
ABActiveOrg 5592734577Ferievägen 15Medical specialists activities · NACE 8622Est. 20201 employees
Revenue 2025
SEK 1,1M
-44% vs 2024
EBITDA margin
27.5%
-42% vs 2024
Equity ratio
61.9%
Financial strength
Net profit 2025
SEK 246K
-42% vs 2024
| Revenue | SEK 1,1M | -44% |
| EBITDA | SEK 302K | -42% |
| Net profit | SEK 246K | -42% |
| Total assets | SEK 1,4M | -24% |
| Equity | SEK 862K | -16% |
| Employees | 1 | — |
Legal name
Daniel Stern Dermatologi AB
Org number
5592734577
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
25 september 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Legitimerad läkare med specialisering inom hudsjukvård. Huvudverksamhet är konsultuppdrag inom sjukvård och relaterad verksamhet. Även uppdrag inom läkemedelsindustrin kan bli aktuellt på sikt.
Address
Ferievägen 15
Email
dani.stern@hotmail.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 220 | 308 | 2 786 | 1 968 | 1 097 |
| Staff expenses | — | −17 | −1 210 | −1 153 | −310 |
| EBITDA | 159 | 248 | 1 468 | 524 | 302 |
| Depreciation & amort. | −0 | — | — | — | −13 |
| EBIT | 159 | 248 | 1 468 | 524 | 288 |
| Net financials | — | −0 | 0 | 19 | 25 |
| Profit before tax | 158 | 186 | 1 099 | 543 | 314 |
| Tax | −34 | −38 | −228 | −115 | −67 |
| Net profit | 124 | 148 | 871 | 427 | 246 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 203 | 377 | 1 757 | 1 819 | 1 392 |
| Equity | 149 | 247 | 968 | 1 023 | 862 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 54 | 68 | 358 | 365 | 99 |
| Total debt | 54 | 68 | 358 | 365 | 99 |
EBITDA margin
27.5%
This company
15.8%
Market median
+74% vs market
20212025
Equity ratio
61.9%
This company
38.2%
Market median
+62% vs market
20212025
Return on equity
28.6%
This company
18.4%
Market median
+55% vs market
20212025
Net profit margin
22.5%
This company
8.1%
Market median
+178% vs market
20212025
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
20212025
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Daniel Stern Dermatologi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hossein Ghate | Deputy Board Member | 0 companies |
| Daniel Stern | Board of Directors | 0 companies |